Why the study?
MASLD is a growing concern in metabolic disorders, particularly in type 2 diabetes mellitus, but its prevalence and risk factors in newly diagnosed patients required investigation.
What is the prevalence and what are the risk factors for MASLD in patients with newly diagnosed type 2 diabetes mellitus?
Population
128 patients with newly diagnosed T2DM
Comparison
Patients with MASLD vs without MASLD
Design
Prospective study
Key result
MASLD was detected in 80.4% of patients with newly diagnosed type 2 diabetes mellitus, with ALT and BMI identified as independent predictors of the disease.
Authors
Loading...
Supports MASLD evaluation in new T2DM; extends observational links to ALT/BMI predictors but leaves practice change open.
Observational (n=128)
What is the prevalence and what are the risk factors for MASLD in patients with newly diagnosed type 2 diabetes mellitus?
There is a high prevalence (80.4%) of MASLD in newly diagnosed T2DM patients, highlighting the need for early screening and detection.
Polat et al. (2025) conducted an observational in Newly diagnosed type 2 diabetes mellitus (n=128). MASLD vs. No MASLD was evaluated on Prevalence of MASLD. MASLD was detected in 80.4% of patients with newly diagnosed type 2 diabetes mellitus, with ALT and BMI identified as independent predictors of the disease.